Literature DB >> 16583468

What are open-label extension studies for?

William J Taylor, Mark Weatherall.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16583468

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

Review 1.  Open-label extension studies: do they provide meaningful information on the safety of new drugs?

Authors:  Richard O Day; Kenneth M Williams
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis.

Authors:  Fernanda S Tonin; Laiza M Steimbach; Leticia P Leonart; Vinicius L Ferreira; Helena H Borba; Thais Piazza; Ariane G Araújo; Fernando Fernandez-Llimos; Roberto Pontarolo; Astrid Wiens
Journal:  Eur J Clin Pharmacol       Date:  2018-07-18       Impact factor: 2.953

3.  Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.

Authors:  Rosa C Lucchetta; Letícia P Leonart; Marcus V M Gonçalves; Jefferson Becker; Roberto Pontarolo; Fernando Fernandez-Llimós; Astrid Wiens
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.